Demyelinating disorders

被引:0
|
作者
Savransky, Andrea [1 ]
机构
[1] Hosp Pediat Prof Dr Juan P Garrahan, Combate Pozos 1881, RA-1245 Buenos Aires, DF, Argentina
关键词
demyelinating diseases; multiple sclerosis; optic neuromyelitis; acute disseminated encephalomyelitis; PEDIATRIC MULTIPLE-SCLEROSIS; ACUTE DISSEMINATED ENCEPHALOMYELITIS; OPTICA SPECTRUM DISORDERS; NEUROMYELITIS-OPTICA; CHILDREN; BRAIN; ANTIBODIES; CRITERIA; MRI; MS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Demyelinating diseases are a group of conditions of autoimmune etiology directed against the myelin of the central nervous system. In many cases, the onset of the illness is preceded by a nonspecific viral infection. Multiple sclerosis is a disease that evolves with relapses and remissions with polyfocal neurological deficits, being the most frequent optic neuritis, transverse myelitis and encephalic trunk involvement. Typically, magnetic resonance image (MRI) shows peri-ventricular, peri-callosal, cerebellum, brain stem and spinal cord hyperintensive lesions in T2 and FLAIR weighted images. Optic neuromyelitis is characterized by the presence of optic neuritis and transverse myelitis associated with the postrema and diencephalic area syndrome. MRI lesions are distributed in sectors rich with aquaporine-4 channels (AQP-4): hypothalamus, third and fourth ventricle, optic nerves and spinal cord. Finding anti AQP4 antibodies is useful for the diagnosis although they are not essential for it. Acute disseminated encephalomyelitis is typically a monophasic condition characterized by acute encephalopathy associated with hyperintense MRI large, bilateral and irregular asymmetric lesion in T2 and FLAIR weighted images. In all three cases, cerebral spine fluid (CSF) can show pleocytosis and hyperproteinorrachia. The presence of oligoclonal bands in CSF is characteristic of multiple sclerosis. In all cases, acute treatment includes high dose intravenous corticosteroids and plasmapheresis in non-responsive cases. Both multiple sclerosis and optic neuromyelitis require long-term treatment to prevent relapse and recurrent diseases.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [1] Demyelinating disorders
    Weber, T.
    Koehler, W.
    NERVENARZT, 2010, 81 (04): : 471 - 496
  • [2] DEMYSTIFYING THE DEMYELINATING DISORDERS
    Wells, Elizabeth
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S131 - S131
  • [3] Connexins in Demyelinating Disorders
    Masaki, K.
    Kira, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) : 516 - 516
  • [4] Management of Demyelinating Disorders in Pregnancy
    Kaplan, Tamara B.
    NEUROLOGIC CLINICS, 2019, 37 (01) : 17 - +
  • [5] AXONAL DEGENERATION IN DEMYELINATING DISORDERS
    MADRID, RE
    WISNIEWSKI, HM
    JOURNAL OF NEUROCYTOLOGY, 1977, 6 (01): : 103 - 117
  • [6] Movement disorders in demyelinating diseases
    Candeias da Silva, C.
    Bichuetti, D. B.
    Azevedo Silva, S. M.
    Ferraz, H. B.
    Oliveira, E. M. L.
    Borges, V.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 163 - 163
  • [7] New biomarker in demyelinating disorders
    Kira, J. I.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 9 - 9
  • [8] Sudden Death in Demyelinating Disorders
    Joseph, J. P.
    Rafia, H.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 954 - 955
  • [9] Recurrent Catatonia and Demyelinating Disorders
    Jiang, Stephanie M.
    Koepsell, Marybeth
    Patel, Bhargav
    Athanasiadi, Argyro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [10] Defining the chromatin landscape in demyelinating disorders
    Huynh, Jimmy Long
    Casaccia, Patrizia
    NEUROBIOLOGY OF DISEASE, 2010, 39 (01) : 47 - 52